載入...

Induction cisplatin–irinotecan followed by concurrent cisplatin–irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial

A recent phase I study showed that weekly cisplatin, irinotecan and concurrent radiotherapy can be administered with moderate toxicity in patients with oesophageal cancer. Patients with no prior treatment and oesophageal cancer stage I to III, performance status <3, caloric intake >1500 kcal d...

全面介紹

Na minha lista:

書目詳細資料
Main Authors:	Michel, P, Adenis, A, Fiore, F Di, Boucher, E, Galais, M P, Dahan, L, Mirabel, X, Hamidou, H, Raoul, J L, Jacob, J H, Hellot, M F, Prod'Homme, S, Paillot, B
格式:	Artigo
語言:	Inglês
出版:	Nature Publishing Group 2006
主題:	Clinical Study
在線閱讀:	https://ncbi.nlm.nih.gov/pmc/articles/PMC2360517/ https://ncbi.nlm.nih.gov/pubmed/16967056 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603328
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

Induction cisplatin–irinotecan followed by concurrent cisplatin–irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial

相似書籍